Get the Stockscreener App
3.15
5.97%
-0.20
After Hours:
3.00
-0.15
-4.76%
Dna X Inc stock is traded at $3.15, with a volume of 52,584.
It is down -5.97% in the last 24 hours and down -28.89% over the past month.
DNA X Inc operates a digital asset management platform.
See More
Previous Close:
$3.35
Open:
$3.61
24h Volume:
52,584
Relative Volume:
0.96
Market Cap:
$4.69M
Revenue:
$59.11M
Net Income/Loss:
$-33.38M
P/E Ratio:
-0.0176
EPS:
-178.995
Net Cash Flow:
$-26.04M
1W Performance:
-4.55%
1M Performance:
-28.89%
6M Performance:
-75.00%
1Y Performance:
-87.76%
1-Day Range:
$2.98
$3.61
1-Week Range:
$2.85
$3.61
52-Week Range:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.15 | 4.99M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corporation
|
411.22 | 2.92T | 305.45B | 119.26B | 77.41B | 15.98 |
ORCL
Oracle Corp
|
169.81 | 468.80B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
142.15 | 324.55B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
411.16 | 101.06B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
438.45 | 80.23B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Global Experts Face-to-Face Interview Series – Redefining Yunnan’s Strategic Value - businessnewsthisweek.com
DNA X, Inc. Reports Full Year 2025 Financial Results - The Globe and Mail
DNA X sold its phone business for $15M to focus on crypto trading - Stock Titan
DNA X (NASDAQ: SONM) narrows 2025 loss and sells mobile unit to fund crypto pivot - Stock Titan
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
How DNA's Double Helix Structure Was Discovered - Britannica
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
DNA Holdings takes 19.99% stake in DNA X, Inc. (SONM) with board rights - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis - Nature
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Feb. 13 Policy Watch: Bipartisan bills target DNA bioweapons, battery supply chain - Chemical & Engineering News
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNA X, Inc. Appoints Mike Mulica as Acting CEO - TradingView — Track All Markets
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dna X Inc Stock (SONM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 10% Owner |
Jun 30 '25 |
Sale |
1.39 |
400,514 |
556,714 |
0 |
| Becher Charles | See Remarks |
Apr 23 '25 |
Sale |
1.45 |
31,326 |
45,423 |
62,668 |
| MULICA MICHAEL C | Director |
Apr 23 '25 |
Sale |
1.45 |
27,818 |
40,336 |
73,292 |
| Crolius Clayton | Chief Financial Officer |
Apr 23 '25 |
Sale |
1.45 |
11,634 |
16,869 |
30,958 |
| Cassano James S | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,126 |
| Wang Jeffrey | Director |
Apr 23 '25 |
Sale |
1.45 |
4,478 |
6,493 |
21,301 |
| Steenstra Jack | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,139 |
2.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):